CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02468986
NCT02468986N/ACompleted

Analysis of Endothelial Cells in Rheumatoid Arthritis

University of Texas Southwestern Medical Center·observational·Posted Jun 11, 2015·Updated Apr 2, 2021

In Brief

An observational study for Rheumatoid Arthritis. Completed, enrolled 56 participants across 2 sites.

Detailed Summary

Heart disease is the major contributor of early death in rheumatoid arthritis (RA) and is not influenced by traditional risk factors. Blood vessel dysfunction has been associated with heart disease and complications such as heart attack. The vessel dysfunction is thought to be mediated in part to inflammation. RA patients have evidence of vessel dysfunction seen on ultrasound that improves after medications are given. The purpose of this study is to evaluate patients with controlled or uncontrolled rheumatoid arthritis to determine if there is a difference in the protein expression in the cells that line the blood vessels compared to healthy people.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 11, 2015
Enrollment StartAug 1, 2011
Primary CompletionAug 1, 2019
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 11.1 years ago